Drug Markets/Cevimeline

Cevimeline

1 NDC across 1 manufacturer|1 Generic,0 Brand

Cevimeline is used to treat rheumatoid arthritis, parotitis and xerostomia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Cevimeline is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.73 to $0.73 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

1G / 0B

Manufacturers

1

competing in market

Price Spread

$0.73 – $0.73

per EA

7d Activity

1↑0 flat

avg +3.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing CEVIMELINE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
CEVIMELINE HCL 30 MG CAPSULE
$0.7289
per EA
+2.95%

Frequently Asked Questions

What is Cevimeline used to treat?

Cevimeline is used to treat rheumatoid arthritis, parotitis and xerostomia, per the National Library of Medicine's MED-RT classification.

How many Cevimeline products are on the market?

The Cevimeline drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.

What is the price range for Cevimeline?

NADAC reference prices for Cevimeline range from $0.7289 to $0.7289 per EA.

Which manufacturers make Cevimeline?

1 manufacturer lists Cevimeline in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (1).

How has the price of Cevimeline changed recently?

Over the past 7 days, 1 Cevimeline NDC rose and 0 fell, with a market-wide average change of +3.0%.